Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S N Wolff

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Blood|August 1, 1990
High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancyR A Brown, R H Herzig, S N Wolff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Allogeneic marrow transplantation for refractory Hodgkin's diseaseG L Phillips, D E Reece, M J Barnett, et al.
Blood|June 1, 1989
Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantationG L Phillips, S N Wolff, R H Herzig, et al.
Blood|February 15, 1990
The treatment of progressive non-Hodgkin's lymphoma with intensive chemoradiotherapy and autologous marrow transplantationG L Phillips, J W Fay, R H Herzig, et al.
Cancer|May 1, 1982
Veno-occlusive disease of the liver after high-dose mitomycin C therapy and autologous bone marrow transplantationH M Lazarus, M R Gottfried, R H Herzig, et al.
Blood|March 15, 1996
Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemiaA F List, C S Spier, T M Grogan, et al.
Bone Marrow Transplantation|May 16, 2000
Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant GroupS N Wolff, J Fay, D Stevens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantationR H Collins, O Shpilberg, W R Drobyski, et al.
Leukemia & Lymphoma|October 8, 1999
Protracted results of dose-intensive therapy using cyclophosphamide, carmustine, and continuous infusion etoposide with autologous stem cell support in patients with relapse or refractory Hodgkin's disease: a phase II study from the North American Marrow Transplant GroupD R Fleming, S N Wolff, J W Fay, et al.
Bone Marrow Transplantation|April 4, 2000
Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemiaZ S Pavletic, E R Arrowsmith, P J Bierman, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Blood|August 1, 1990
High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancyR A Brown, R H Herzig, S N Wolff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Allogeneic marrow transplantation for refractory Hodgkin's diseaseG L Phillips, D E Reece, M J Barnett, et al.
Blood|June 1, 1989
Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantationG L Phillips, S N Wolff, R H Herzig, et al.
Blood|February 15, 1990
The treatment of progressive non-Hodgkin's lymphoma with intensive chemoradiotherapy and autologous marrow transplantationG L Phillips, J W Fay, R H Herzig, et al.
Cancer|May 1, 1982
Veno-occlusive disease of the liver after high-dose mitomycin C therapy and autologous bone marrow transplantationH M Lazarus, M R Gottfried, R H Herzig, et al.
Blood|March 15, 1996
Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemiaA F List, C S Spier, T M Grogan, et al.
Bone Marrow Transplantation|May 16, 2000
Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant GroupS N Wolff, J Fay, D Stevens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantationR H Collins, O Shpilberg, W R Drobyski, et al.
Leukemia & Lymphoma|October 8, 1999
Protracted results of dose-intensive therapy using cyclophosphamide, carmustine, and continuous infusion etoposide with autologous stem cell support in patients with relapse or refractory Hodgkin's disease: a phase II study from the North American Marrow Transplant GroupD R Fleming, S N Wolff, J W Fay, et al.
Bone Marrow Transplantation|April 4, 2000
Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemiaZ S Pavletic, E R Arrowsmith, P J Bierman, et al.
Pageof 10